Qorvo QRVO 深 滬
已收盤 12-12 16:00:00 美东时间
88.07
-1.340
-1.50%
華盛通- 最 高89.96
- 今 開89.04
- 成交量 121.56万股
- 最 低 87.68
- 昨 收 89.41
- 總市值 81.37亿
- 52周最高 106.30
- 市盈率 靜 151.14
- 換手率 1.32%
- 52周最低 49.46
- 委 比 31.03%
- 總股本 9239.69万
- 歷史最高 201.68
- 量 比 1.31
- 振 幅 2.55%
- 歷史最低 13.80
- 每 手 1
- 風險率 9.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多今年美国科技行业并购活动反弹至2021年以来最高水平
今年，美国科技行业的并购活动反弹至2021年以来的最高水平，推动力来自对人工智能的巨大投入，以及在对并购更加友好的总统政府下促成的更多交易。 据统计，科...
12-09 16:28
Intel, Qualcomm, Adobe, others seen as 'AI losers,' Wedbush says
Artificial intelligence is completely altering how various industries spend their money, benefiting companies such as Nvidia (NVDA), AMD (AMD) and others. And while there may be some winners, Wedbush ...
12-08 20:42
Qorvo Announces Retention Bonus Amid Skyworks Merger
Qorvo ( ($QRVO) ) just unveiled an update. On November 22, 2025, Qorvo, Inc. an...
11-29 05:30
Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering
Thermo Fisher Scientific (TMO) announced that it has priced an offering of €2.1 billion in euro-denominated notes, to be issued by its finance subsidiary Thermo Fisher Scientific (Finance I) B.V., tha...
11-25 15:02
Shares of companies in the broader chip sector are trading lower, reversing following an earlier NVIDIA-driven rally.
Shares of companies in the broader chip sector are trading lower, reversing fol...
11-21 01:17
CSG Systems International declares $0.32 dividend
CSG Systems International (CSGS) declares $0.32/share quarterly dividend, in line with previous. Forward yield 1.63% Payable Jan. 6; for shareholders of record Dec. 22; ex-div Dec. 22. See CSGS Divide...
11-14 21:43
Novartis says novel antimalarial succeeded in late-stage trial
Novartis (NVS) (OTCPK:NVSEF) has announced that its next-generation malaria treatment, KLU156 (GanLum), developed with Swiss nonprofit Medicines for Malaria Venture, reached the primary endpoint in a ...
11-13 22:14
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
华尔街顶级分析师最新评级报告：DraftKings评级下调
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总。以下是由 The Fly 整理的今日投资者需关注的研究评级信息。 五大评级上调标的 蒙特利尔银行资...
11-11 23:03
